NYSE American - Delayed Quote USD
NeurAxis, Inc. (NRXS)
2.2660
-0.0340
(-1.48%)
At close: May 14 at 3:59:53 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.23 | -0.23 | -1.04 | -0.51 |
| Low Estimate | -0.23 | -0.23 | -1.04 | -0.51 |
| High Estimate | -0.23 | -0.23 | -1.04 | -0.51 |
| Year Ago EPS | -- | -- | -- | -1.04 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 917.25k | 1M | 4.06M | 8M |
| Low Estimate | 917.25k | 1M | 4.06M | 8M |
| High Estimate | 917.25k | 1M | 4.06M | 8M |
| Year Ago Sales | -- | -- | -- | 4.06M |
| Sales Growth (year/est) | -- | -- | -- | 96.90% |
Earnings History
| Currency in USD | 12/31/2024 | 3/31/2025 |
|---|---|---|
| EPS Est. | -- | -0.24 |
| EPS Actual | -0.21 | -0.33 |
| Difference | -- | -0.09 |
| Surprise % | -- | -37.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.23 | -1.04 | -0.51 |
| 7 Days Ago | -0.25 | -0.24 | -0.98 | -0.51 |
| 30 Days Ago | -0.25 | -0.24 | -0.98 | -0.51 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NRXS | -- | -- | -- | 50.96% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Related Tickers
KLRS Kalaris Therapeutics, Inc.
3.3800
+4.00%
LIMN Liminatus Pharma, Inc.
6.50
-1.52%
BRTX BioRestorative Therapies, Inc.
1.7100
-2.29%
CALC CalciMedica, Inc.
1.9130
-0.88%
ASBP Aspire Biopharma Holdings, Inc.
0.2377
-27.53%
AVTX Avalo Therapeutics, Inc.
3.6000
-2.17%
CSBR Champions Oncology, Inc.
6.47
+3.60%
AKTX Akari Therapeutics, Plc
1.3500
-0.74%
ATHA Athira Pharma, Inc.
0.2597
-7.25%
TTNP Titan Pharmaceuticals, Inc.
4.7600
+3.48%